New drug combo aims to tame rare inflammatory disease
Disease control
Not yet recruiting
This study tests two experimental drugs, goflikicept and olokizumab, in 52 adults with Still's disease, a rare inflammatory condition. The goal is to see if these drugs can quickly bring the disease under control and keep it from flaring up. Participants will receive either the s…
Phase: PHASE3 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC